121 related articles for article (PubMed ID: 8865192)
1. Electrophysiological, behavioural and biochemical evidence for activation of brain noradrenergic systems following neurokinin NK3 receptor stimulation.
Jung M; Michaud JC; Steinberg R; Barnouin MC; Hayar A; Mons G; Souilhac J; Emonds-Alt X; Soubrié P; Le Fur G
Neuroscience; 1996 Sep; 74(2):403-14. PubMed ID: 8865192
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo characterization of NK3 receptors in the rabbit eye by use of selective non-peptide NK3 receptor antagonists.
Medhurst AD; Hay DW; Parsons AA; Martin LD; Griswold DE
Br J Pharmacol; 1997 Oct; 122(3):469-76. PubMed ID: 9351503
[TBL] [Abstract][Full Text] [Related]
3. Biochemical and pharmacological activities of SSR 146977, a new potent nonpeptide tachykinin NK3 receptor antagonist.
Emonds-Alt X; Proietto V; Steinberg R; Advenier C; Daoui S; Naline E; Gueudet C; Michaud JC; Oury-Donat F; Poncelet M; Vilain P; Le Fur G; Maffrand JP; Soubrié P; Pascal M
Can J Physiol Pharmacol; 2002 May; 80(5):482-8. PubMed ID: 12056557
[TBL] [Abstract][Full Text] [Related]
4. Characterization of NK3 receptors in rabbit isolated iris sphincter muscle.
Medhurst AD; Parsons AA; Roberts JC; Hay DW
Br J Pharmacol; 1997 Jan; 120(1):93-101. PubMed ID: 9117105
[TBL] [Abstract][Full Text] [Related]
5. Study of SR 142801, a new potent non-peptide NK3 receptor antagonist on cardiovascular responses in conscious guinea-pig.
Roccon A; Marchionni D; Nisato D
Br J Pharmacol; 1996 Jul; 118(5):1095-102. PubMed ID: 8818331
[TBL] [Abstract][Full Text] [Related]
6. Effect of SR 142801 on nitric oxide-dependent and independent responses to tachykinin NK3 receptor agonists in isolated guinea-pig colon.
Giuliani S; Maggi CA
Naunyn Schmiedebergs Arch Pharmacol; 1995 Nov; 352(5):512-9. PubMed ID: 8751080
[TBL] [Abstract][Full Text] [Related]
7. Tachykinin NK3 receptor mediates NANC hyperpolarization and relaxation via nitric oxide release in the circular muscle of the guinea-pig colon.
Maggi CA; Zagorodnyuk V; Giuliani S
Regul Pept; 1994 Oct; 53(3):259-74. PubMed ID: 7531357
[TBL] [Abstract][Full Text] [Related]
8. Localization of Fos-like immunoreactivity induced by the NK3 tachykinin receptor agonist, senktide, in the guinea-pig brain.
Yip J; Chahl LA
Br J Pharmacol; 1997 Oct; 122(4):715-25. PubMed ID: 9375969
[TBL] [Abstract][Full Text] [Related]
9. Permissive role of neurokinin NK(3) receptors in NK(1) receptor-mediated activation of the locus coeruleus revealed by SR 142801.
Bert L; Rodier D; Bougault I; Allouard N; Le-Fur G; Soubrié P; Steinberg R
Synapse; 2002 Jan; 43(1):62-9. PubMed ID: 11746734
[TBL] [Abstract][Full Text] [Related]
10. Activation of dopaminergic and cholinergic neurotransmission by tachykinin NK3 receptor stimulation: an in vivo microdialysis approach in guinea pig.
Marco N; Thirion A; Mons G; Bougault I; Le Fur G; Soubrié P; Steinberg R
Neuropeptides; 1998 Oct; 32(5):481-8. PubMed ID: 9845011
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular and behavioural effects of intracerebroventricularly administered tachykinin NK3 receptor antagonists in the conscious rat.
Cellier E; Barbot L; Regoli D; Couture R
Br J Pharmacol; 1997 Oct; 122(4):643-54. PubMed ID: 9375960
[TBL] [Abstract][Full Text] [Related]
12. Neuronal tachykinin NK2 receptors mediate release of non-adrenergic non-cholinergic inhibitory transmitters in the circular muscle of guinea-pig colon.
Zagorodnyuk V; Maggi CA
Neuroscience; 1995 Nov; 69(2):643-50. PubMed ID: 8552256
[TBL] [Abstract][Full Text] [Related]
13. The tachykinin NK3 receptor agonist senktide induces locomotor activity in male Mongolian gerbils.
Nordquist RE; Durkin S; Jacquet A; Spooren W
Eur J Pharmacol; 2008 Dec; 600(1-3):87-92. PubMed ID: 18930726
[TBL] [Abstract][Full Text] [Related]
14. Senktide-induced gerbil foot tapping behaviour is blocked by selective tachykinin NK1 and NK3 receptor antagonists.
Sundqvist M; Kristensson E; Adolfsson R; Leffler A; Ahlstedt I; Engberg S; Drmota T; Sigfridsson K; Jussila R; de Verdier J; Novén A; Johansson A; Påhlman I; von Mentzer B; Lindström E
Eur J Pharmacol; 2007 Dec; 577(1-3):78-86. PubMed ID: 17920583
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo characterization of the non-peptide NK3 receptor antagonist SB-223412 (talnetant): potential therapeutic utility in the treatment of schizophrenia.
Dawson LA; Cato KJ; Scott C; Watson JM; Wood MD; Foxton R; de la Flor R; Jones GA; Kew JN; Cluderay JE; Southam E; Murkitt GS; Gartlon J; Pemberton DJ; Jones DN; Davies CH; Hagan J
Neuropsychopharmacology; 2008 Jun; 33(7):1642-52. PubMed ID: 17728699
[TBL] [Abstract][Full Text] [Related]
16. In vivo evidence for the involvement of tachykinin NK3 receptors in the hexamethonium-resistant inhibitory transmission in the rat colon.
Lecci A; Giuliani S; Tramontana M; Meini S; De Giorgio R; Maggi CA
Naunyn Schmiedebergs Arch Pharmacol; 1996 May; 353(6):671-9. PubMed ID: 8738300
[TBL] [Abstract][Full Text] [Related]
17. SR 142801, the first potent non-peptide antagonist of the tachykinin NK3 receptor.
Emonds-Alt X; Bichon D; Ducoux JP; Heaulme M; Miloux B; Poncelet M; Proietto V; Van Broeck D; Vilain P; Neliat G
Life Sci; 1995; 56(1):PL27-32. PubMed ID: 7830490
[TBL] [Abstract][Full Text] [Related]
18. NK3 receptors mediate an increase in firing rate of midbrain dopamine neurons of the rat and the guinea pig.
Werkman TR; McCreary AC; Kruse CG; Wadman WJ
Synapse; 2011 Aug; 65(8):814-26. PubMed ID: 21218451
[TBL] [Abstract][Full Text] [Related]
19. Mapping the binding pocket of a novel, high-affinity, slow dissociating tachykinin NK3 receptor antagonist: biochemical and electrophysiological characterization.
Malherbe P; Knoflach F; Marcuz A; Bohnert C; Weber M; Knust H; Ratni H; Spooren W; Ballard TM; Bissantz C
Neuropharmacology; 2014 Nov; 86():259-72. PubMed ID: 25107588
[TBL] [Abstract][Full Text] [Related]
20. Evidence for modulation of dopamine-neuronal function by tachykinin NK3 receptor stimulation in gerbil mesencephalic cell cultures.
Alonso R; Fournier M; Carayon P; Petitpretre G; Le Fur G; Soubrié P
Eur J Neurosci; 1996 Apr; 8(4):801-8. PubMed ID: 9081631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
